3,2 %HIV incidence among non-Ivorian female sex workers in Côte d'Ivoire was 3.2%.
Côte d'IvoireVIH/sidaobservé 2016-2017publié 2022PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0271988
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
369 evidences · page 1 / 15
3,2 %HIV incidence among non-Ivorian female sex workers in Côte d'Ivoire was 3.2%.
Côte d'IvoireVIH/sidaobservé 2016-2017publié 2022PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0271988
62 patientsWe studied 62 patients (44 men, 18 women).
Côte d'IvoireVIH/sidaobservé 1999–2006publié 2010Le Mali medicaleurope_pmcdocument de 17 observations
58 %Among hospitalized HIV-positive adults in West Africa, 58% were women.
Côte d'IvoireVIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797
14,3 %Among HIV-infected pregnant women exposed to efavirenz (EFV) during the first trimester, the proportion of abortion was 14.3%.
Côte d'IvoireVIH/sidaobservé 2003–2009publié 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0b013e3181ff04e6
25 %Of the patients with detectable viral loads at month 24, 25% still did not harbor resistant virus.
Côte d'IvoireVIH/sidapublié 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 11 observations
0,5 %At 10 years, scale-back strategies increase projected HIV transmissions by 0.5% to 19.4%.
Côte d'IvoireVIH/sidaobservé 10 yearspublié 2017Annals of internal medicineeurope_pmcdocument de 6 observations
33,3 %Among 66 HBsAg-positive patients, 33.3% were inactive HBV carriers.
Côte d'Ivoirehépatite B · VIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations
35,3 %Among the 17 patients remaining in care, six (35.3%) had an undetectable viral load.
Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642
0 casesNo case of HIV seroconversion was reported 6 months after exposure among AEB victims.
Côte d'IvoireVIH/sidaobservé 6 month after exposurepublié 2007Medecine et maladies infectieuseseurope_pmcdocument de 11 observations
47,3 %At month 36, 47.3% of the patients were lost to follow-up.
Côte d'IvoireVIH/sidapublié 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument de 7 observations
3 %HIV incidence among female sex workers aged 24 years or less in Côte d'Ivoire was 3.0%.
Côte d'IvoireVIH/sidaobservé 2016-2017publié 2022PloS oneeurope_pmcdocument de 10 observationsDOI 10.1371/journal.pone.0271988
169 cells/mm³In ART-treated patients, the CD4 count increased by 169 cells/mm³ after 24 months on ART for dually seropositive patients.
Côte d'IvoireVIH/sidaobservé 24 monthspublié 2013PloS oneeurope_pmcdocument de 14 observations
280 cells/mm3Patients in the deferred group who started ART had a lower median CD4 count (280 cells/mm3) at baseline.
Côte d'IvoireVIH/sidapublié 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument de 8 observations
13,4 %HBsAg prevalence was 13.4% among 491 adult HIV patients in Abidjan.
Côte d'Ivoirehépatite B · VIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations
50 %50% of the patients (14 out of 28) were antiretroviral therapy experienced.
Côte d'IvoireVIH/sidapublié 2025IJID regionseurope_pmcdocument de 11 observations
13,2 per_100_person_yearsAfter a median 2.0 year follow-up, the incidence rate of serious HIV-related events was 13.2 per 100 person-years among HIV-HBV co-infected patients.
Côte d'Ivoirehépatite B · VIH/sidapublié 2017The American journal of tropical medicine and hygieneeurope_pmcdocument de 7 observationsDOI 10.4269/ajtmh.16-1016
32,3 %The main biological effect was hypertransaminasaemia > 2N (32.3%).
Côte d'IvoireVIH/sidapublié 2010Le Mali medicaleurope_pmcdocument de 17 observations
243 cells/mm³Last available CD4(+) T-cell counts were 243 cells/mm³, 245 cells/mm³, and 8 cells/mm³ for the three patients.
Côte d'IvoireVIH/sidapublié 2009Antiviral therapyeurope_pmcdocument de 11 observations
90 %The survival analysis showed a probability of remaining alive and in care of 90% after 24 months.
Côte d'IvoireVIH/sidapublié 2025PloS oneeurope_pmcdocument de 12 observations
360 cells/μlMedian CD4 cell count was 360 cells/μl.
Côte d'IvoireVIH/sidapublié 2014AIDS (London, England)europe_pmcdocument de 9 observations
379 cells/mm³Four hundred seventy-seven patients had a median CD4 count of 379 cells/mm³.
Côte d'IvoireVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 6 observations
7,1 %HIV prevalence among first-time blood donors in Abidjan decreased from 7.1% in 1992–1994 to 1.1% in 2010–2012.
Côte d'IvoireVIH/sidaobservé 1992–1994publié 2018Open forum infectious diseaseseurope_pmcdocument de 12 observations
200 USDThe cost of HIV drug resistance testing was assumed to be $200.
Côte d'IvoireVIH/sidapublié 2025The lancet. HIVeurope_pmcdocument de 6 observations
0,85 per_100_person-yearsThe incidence of severe hyperlactatemia was 0.85 per 100 person-years among women on stavudine-containing antiretroviral regimens in Côte d'Ivoire between April 2005 and May 2009.
Côte d'IvoireVIH/sidaobservé between April 2005 and May 2009publié 2010AIDS research and human retroviruseseurope_pmcdocument de 12 observations
2 patientsTwo patients (3.2%) died.
Côte d'IvoireVIH/sidapublié 2010Le Mali medicaleurope_pmcdocument de 17 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.